More PRNewswire

View Older Stories View Newer Stories

Sep 29, 2025 08:30AM Gamehaus Holdings Inc. Announces International Launch of Monster Maidens: Edenfall, Advancing "Gamehaus 2.0" Strategy
Sep 29, 2025 08:29AM Vee Healthtek Announces Acquisition of Precision Practice Management to Expand Ambulatory Market Footprint and Technology Capabilities
Sep 29, 2025 08:27AM Amber Premium and CMGE Join Forces to Drive RWA Innovation for the Iconic IP The Legend of Sword and Fairy
Sep 29, 2025 08:26AM DayTrading.com Publishes New Study Showing 70% Of Viral Finance TikToks Are Misleading
Sep 29, 2025 08:20AM Young America Capital Advises Cloud Carib in Strategic Growth Financing from Partners for Growth
Sep 29, 2025 08:19AM WiMi's Lays out for the Research on Distributed Quantum Computing Based on Cross-Optical Network Links
Sep 29, 2025 08:19AM DAR AL ARKAN PLANS TO LAUNCH "MANHATTAN" MASTERPLAN IN JEDDAH, A LANDMARK DESTINATION ON KING ABDULAZIZ ROAD FEATURING 'TRUMP PLAZA'
Sep 29, 2025 08:17AM Beacon Global Strategies Announces Launch of International Trade Practice, Welcomes Sara Schuman as Managing Director
Sep 29, 2025 08:15AM MacPaw Announces Jamf Marketplace Partnership and Strategic Leadership Appointments for CleanMyMac Business
Sep 29, 2025 08:15AM Blazeo Launches Hybrid Voice AI, Blending Automation and Human Agents to Redefine Call Centers
Sep 29, 2025 08:15AM The Truth Behind Egypt's Stolen Legacy: Livestream
Sep 29, 2025 08:09AM Mosaic Consulting Expands Salesforce and Braze Services, Showcases Software Expertise with DrugAlert.ai
Sep 29, 2025 08:09AM Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
Sep 29, 2025 08:09AM OULA PROVIDED BY STAMFORD HEALTH OPENS NEW MATERNITY CLINIC IN CONNECTICUT
Sep 29, 2025 08:05AM Novo Nordisk resubmits Awiqli® to the FDA with potential to be the first once-weekly basal insulin treatment for adults with type 2 diabetes
Sep 29, 2025 08:05AM Vascarta Announces Completion of Phase 1 Clinical Trial of VAS-101 for the Treatment of Osteoarthritis
Sep 29, 2025 08:05AM Atlanta Beltline Issues Request for Proposals for Transformative Development at 356 University Avenue
Sep 29, 2025 08:03AM Parry Labs Works with US Marine Corps Demonstration to Explore New 'Colorless' Data Transfer Approaches
Sep 29, 2025 08:03AM CeraVe and L'Oréal Groupe Win Prestigious IFSCC Applied Research Award for Breakthrough Dandruff Study
Sep 29, 2025 08:02AM Applications Now Open for the 7th Guangzhou Award
Sep 29, 2025 08:00AM Burford Capital Interim Dividend Declaration
Sep 29, 2025 08:01AM BenQ Launches GV32 LED Ceiling Projector for All-in-One, Grab-and-Go Home Entertainment
Sep 29, 2025 08:00AM ADP to Announce First Quarter Fiscal 2026 Financial Results on October 29, 2025
Sep 29, 2025 08:00AM Robert Half Releases 2026 Salary Guide Highlighting Key Compensation Trends Amid a Complex Job Market
Sep 29, 2025 08:00AM FusionIQ Continues Building End-to-End Digital Wealth Management Platform With Latest Fintech Partnership
Sep 29, 2025 08:00AM HPA Exchange Launches $9.67 Million DST Offering of Specialty Children's Hospital in Dallas
Sep 29, 2025 08:00AM AENTS Provides End-to-End Carbon Management Platform to Accelerate Net-Zero Transition
Sep 29, 2025 08:00AM Achieve promotes Jason Yee to Chief Financial Officer
Sep 29, 2025 08:00AM Coya Therapeutics Announces Completion of Patient Enrollment of an Investigator-Initiated, Open-Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Patients with Mild to Moderate Fron
Sep 29, 2025 08:00AM Resonetics® Acquires Eden Holdings, Adding Injection Molding to its Capabilities
Sep 29, 2025 08:00AM Cuisinart® Launches Custom Grind & Brew™ Single-Cup Coffee Maker: A Pod-Free, Bean-to-Cup Breakthrough for Coffee Lovers
Sep 29, 2025 08:00AM CME Group Files to Expand FICC Cross-Margining to End User Clients
Sep 29, 2025 08:00AM PACKSIZE EFI X5 NOZOMI DELIVERS PERSONALIZATION BY THE BOX FOR ECOMMERCE AND RETAILERS
Sep 29, 2025 08:00AM EY Pulse of the MedTech Industry Report 2025: MedTech vital signs are robust, reigniting growth and expanding markets in a disrupted healthcare landscape
Sep 29, 2025 08:00AM Daesang to Participate in ANUGA 2025, the World's Largest Food Trade Fair, Highlighting European Market Expansion
Sep 29, 2025 08:00AM Nespresso Marks National Coffee Day with Insights on Coffee and Mental Wellbeing from New Survey with Project Healthy Minds
Sep 29, 2025 08:00AM Frederick Entrepreneur Chad Smith Launches Elite Acquisition Blueprint: A Step-by-Step System Helping Small Businesses Turn Strangers Into Clients, On Demand
Sep 29, 2025 08:00AM CPDC Launches Cadena Research, a Radiopharmaceutical Preclinical CRO
Sep 29, 2025 08:00AM Uber Eats Adds Citarella and More Regional Favorites to Growing Grocery Marketplace
Sep 29, 2025 08:00AM U Power Partners with IoTeX to Launch Tokenized Real-World Assets, Pioneering AI-Powered Web3 EV Battery Swapping Infrastructure
Sep 29, 2025 08:00AM The Practice Plastic Surgery Evolves into The Practice Healthcare, Expanding into Wellness and Gynecology, to Redefine Modern Health
Sep 29, 2025 08:00AM March Networks Launches AI3 Counting Camera for 360° Visual Intelligence at GSX 2025
Sep 29, 2025 08:00AM Lightspeed Commerce Unveils Showroom: A Digital Showcase for Brick-and-Mortar Retailers
Sep 29, 2025 08:00AM New Research Asks and Answers the Question: How Do Medical Practices Retain Early-Career Physicians?
Sep 29, 2025 08:00AM Ontario International Airport awarded $10.81 million FAA grant for critical infrastructure improvements
Sep 29, 2025 08:00AM PARAMOUNT ANNOUNCES LANDMARK MEDIA RIGHTS AGREEMENT WITH ZUFFA BOXING
Sep 29, 2025 08:00AM Monster Energy's Camille Balanche Takes Second Place in Pro Women Downhill Mountain Bike at Fox US Open of Mountain Biking in Killington
Sep 29, 2025 08:00AM Hyundai Mobis Partners with Over 20 Companies to Foster the K-Automotive Semiconductor
Sep 29, 2025 08:00AM Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors
Sep 29, 2025 08:00AM U.S. FDA approves TREMFYA® (guselkumab) for the treatment of pediatric plaque psoriasis and active psoriatic arthritis, marking a first and only approval for an IL-23 inhibitor
View Newer Stories View Older Stories